What’s New in Prevention of Invasive Fungal Diseases during Hospital Construction and Renovation Work: An Overview
Abstract
:1. Introduction
2. Construction and Renovation in Healthcare Settings as a Source of Fungi
2.1. Permanent Need for Construction and Renovation
2.2. How Construction Work Affects the Burden of Fungi and the Patients
3. Outbreaks of Invasive Fungal Infections Associated with Hospital Construction and Renovation
3.1. Burden of Outbreaks
3.2. Fungal Species Involved in Outbreaks
4. Infection Prevention and Control Measures
4.1. Infection Control Risk Assessment (ICRA)
4.1.1. ICRA Precaution Matrix
4.1.2. Precaution Classes
- an additional category (Class V) is formed because four classes limited the ability to properly address large-scale projects; namely, in addition to mitigation activities performed before and during work comprised by Class IV, Class V includes the need to construct an anteroom large enough for equipment staging, cart cleaning, and workers that must be constructed adjacent to the entrance of the construction work area, as well as the requirement for personnel to wear disposable coveralls at all times during Class V activities and that must be removed before leaving the anteroom;
- Class II must never be used for construction or renovation activities;
- the development of an ICRA process guide on how the ICRA should be implemented [50].
4.2. High-Efficiency Particulate Air (HEPA) Filters
4.3. Air Sampling
4.4. Do FFP2 Masks Have Protective Roles for Immunocompromised Patients during Construction and Renovation Works?
4.5. Antifungal Prophylaxis
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Vallabhaneni, S.; Mody, R.K.; Walker, T.; Chiller, T. The global burden of fungal diseases. Infect. Dis. Clin. N. Am. 2016, 30, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Webb, B.J.; Ferraro, J.P.; Rea, S.; Kaufusi, S.; Goodman, B.E.; Spalding, J. Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care Network. Open Forum Infect. Dis. 2018, 5, ofy187. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Firacative, C. Invasive fungal disease in humans: Are we aware of the real impact? Mem. Inst. Oswaldo Cruz. 2020, 115, e200430. [Google Scholar] [CrossRef] [PubMed]
- Rayens, E.; Norris, K.A. Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018. Open Forum Infect. Dis. 2022, 9, ofab593. [Google Scholar] [CrossRef]
- Walsh, T.J.; Dixon, D.M. Nosocomial aspergillosis: Environmental microbiology, hospital epidemiology, diagnosis and treatment. Eur. J. Epidemiol. 1989, 5, 131–142. [Google Scholar] [CrossRef]
- Wyatt, T.T.; Wösten, H.A.; Dijksterhuis, J. Fungal spores for dispersion in space and time. Adv. Appl. Microbiol. 2013, 85, 43–91. [Google Scholar]
- Segers, F.J.J.; Dijksterhuis, J.; Giesbers, M.; Debets, A.J.M. Natural folding of airborne fungal spores: A mechanism for dispersal and long-term survival. Fungal Biol. Rev. 2023, 44, 100292. [Google Scholar] [CrossRef]
- Valsecchi, I.; Dupres, V.; Stephen-Victor, E.; Guijarro, J.I.; Gibbons, J.; Beau, R.; Bayry, J.; Coppee, J.Y.; Lafont, F.; Latgé, J.P.; et al. Role of Hydrophobins in Aspergillus fumigatus. J. Fungi 2017, 4, 2. [Google Scholar] [CrossRef] [Green Version]
- Kwon-Chung, K.J.; Sugui, J.A. Aspergillus fumigatus—What Makes the Species a Ubiquitous Human Fungal Pathogen? PLoS Pathog. 2013, 9, e1003743. [Google Scholar] [CrossRef]
- Aisner, J.; Schimpff, S.C.; Bennett, J.E.; Young, V.M.; Wiernik, P.H. Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. JAMA 1976, 235, 411–412. [Google Scholar] [CrossRef]
- Vonberg, R.P.; Gastmeier, P. Nosocomial aspergillosis in outbreak setting. J. Hosp. Infect. 2006, 63, 246–254. [Google Scholar] [CrossRef] [PubMed]
- Viegas, C.; Almeida, B.; Gomes, A.Q.; Carolino, E.; Caetano, L.A. Aspergillus spp. prevalence in Primary Health Care Centres: Assessment by a novel multi-approach sampling protocol. Environ. Res. 2019, 175, 133–141. [Google Scholar] [CrossRef] [PubMed]
- Krasinski, K.; Holzman, R.S.; Hanna, B.; Greco, M.A.; Graff, M.; Bhogal, M. Nosocomial fungal infection during hospital renovation. Infect. Control 1985, 6, 278–282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garnaud, C.; Brenier-Pinchart, M.P.; Thiebaut-Bertrand, A.; Hamidfar, R.; Quesada, J.L.; Bosseray, A.; Lebeau, B.; Mallaret, M.R.; Maubon, D.; Saint-Raymond, C.; et al. Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital. J. Infect. 2012, 65, 559–567. [Google Scholar] [CrossRef] [PubMed]
- Nakanishi, Y.; Kasahara, K.; Koizumi, A.; Tokutani, J.; Yoshihara, S.; Mikasa, K.; Imamura, T. Evaluation of Nosocomial Infection Control Measures to Minimize the Risk of Aspergillus Dispersion During Major Demolition Work: A Case Study of a Japanese University Hospital. HERD 2021, 14, 58–74. [Google Scholar] [CrossRef] [PubMed]
- Ulrich, R.S.; Berry, L.L.; Quan, X.; Parish, J.T. A Conceptual Framework for the Domain of Evidence-Based Design. HERD 2010, 4, 95–114. [Google Scholar] [CrossRef] [PubMed]
- Building 4 People: Building the Business Case for Better Office, School and Hospital Buildings in Europe. Available online: www.bpie.eu/wp-content/uploads/2018/12/market_paper_031218.pdf (accessed on 3 December 2022).
- Demolition and Damaged Structures. Available online: https://ohsguide.ihsa.ca/en/topic/demolition.html#:~:text=Demolition%20is%20the%20act%20of,to%20a%20heavily%20mechanical%20one (accessed on 3 December 2022).
- Weems, J.J., Jr.; Davis, B.J.; Tablan, O.C.; Kaufman, L.; Martone, W.J. Construction activity: An independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infect. Control 1987, 8, 71–75. [Google Scholar] [CrossRef]
- Ortiz, S.C.; Pennington, K.; Thomson, D.D.; Bertuzzi, M. Novel Insights into Aspergillus fumigatus Pathogenesis and Host Response from State-of-the-Art Imaging of Host-Pathogen Interactions during Infection. J. Fungi 2022, 8, 264. [Google Scholar] [CrossRef]
- Weber, S.F.; Peacock, J.E., Jr.; Do, K.A.; Cruz, J.M.; Powell, B.L.; Capizzi, R.L. Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders. Infect. Control Hosp. Epidemiol. 1990, 11, 235–242. [Google Scholar] [CrossRef]
- Haiduven, D. Nosocomial aspergillosis and building contructions. Med. Mycol. 2009, 47, S210–S216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kanamori, H.; Rutala, W.A.; Sickbert-Bennett, E.E.; Weber, D.J. Review of fungal outbreaks and infection prevention in Healthcare settings during construction and renovation. Clin. Infect. Dis. 2015, 61, 433–444. [Google Scholar] [CrossRef] [PubMed]
- Alvarez, M.; Lopez Ponga, B.; Rayon, C.; Garcia Gala, J.; Roson Porto, M.C.; Gonzalez, M.; Martinez-Suarez, J.V.; Rodriguez-Tudela, J.L. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): Four fatal cases in leukemic patients. J. Clin. Microbiol. 1995, 33, 3290–3295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pokala, H.R.; Leonard, D.; Cox, J.; Metcalf, P.; McClay, J.; Siegel, J.; Winick, N. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia. Pediatr Blood Cancer. 2014, 6, 276–280. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sautour, M.; Edel-Hermann, V.; Steinberg, C.; Sixt, N.; Laurent, J.; Dalle, F.; Aho, S.; Hartemann, P.; L’ollivier, C.; Goyer, M.; et al. Fusarium species recovered from the water distribution system of a French university hospital. Int. J. Hyg. Environ. Health 2012, 215, 286–292. [Google Scholar] [CrossRef]
- Abdel Hameed, A.A.; Yasser, I.H.; Khoder, I.M. Indoor air quality during renovation actions: A case study. J. Environ. Monit. 2004, 6, 740–744. [Google Scholar] [CrossRef]
- Gastmeier, P.M.; Stamm-Balderjahn, S.; Hansen, S.; Nitzschke-Tiemann, F.; Zuschneid, I.; Groneberg, K.; Rüden, H. How outbreaks can contribute to prevention of nosocomial infection: Analysis of 1,022 outbreaks. Infect. Control Hosp. Epidemiol. 2005, 26, 357–361. [Google Scholar] [CrossRef]
- Barreiros, G.; Akiti, T.; Magalhães, A.C.; Nouér, S.A.; Nucci, M. Effect of the implosion and demolition of a hospital building on the concentration of fungi in the air. Mycoses 2015, 58, 707–713. [Google Scholar] [CrossRef]
- Gheith, S.; Ranque, S.; Bannour, W.; Ben Youssef, Y.; Khelif, A.; Ben Said, M.; Njah, M.; Saghrouni, F. Hospital environment fungal contamination and aspergillosis risk in acute leukaemia patients in Sousse (Tunisia). Mycoses 2015, 58, 337–342. [Google Scholar] [CrossRef]
- Loschi, M.; Thill, C.; Gray, C.; David, M.; Bagatha, M.F.; Chamseddine, A.; Contentin, N.; Jardin, F.; Lanic, H.; Lemasle, E.; et al. Invasive aspergillosis in neutropenic patients during hospital renovation: Effectiveness of mechanical preventive measures in a prospective cohort of 438 patients. Mycopathologia 2015, 179, 337–345. [Google Scholar] [CrossRef]
- Özen, M.; Yılmaz, G.; Coşkun, B.; Topçuoğlu, P.; Öztürk, B.; Gündüz, M.; Atilla, E.; Arslan, Ö.; Özcan, M.; Demirer, T.; et al. A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction. Turk. J. Haematol. 2016, 33, 41–47. [Google Scholar] [CrossRef]
- Kabbani, D.; Goldraich, L.; Ross, H.; Rotstein, C.; Husain, S. Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis. Transp. Infect. Dis. 2018, 20, e12808. [Google Scholar] [CrossRef] [PubMed]
- Combariza, J.F.; Toro, L.F.; Orozco, J.J. Effectiveness of environmental control measures to decrease the risk of invasive aspergillosis in acute leukaemia patients during hospital building work. J. Hosp. Infect. 2017, 96, 336–341. [Google Scholar] [CrossRef]
- Wirmann, L.; Ross, B.; Reimann, O.; Steinmann, J.; Rath, P.-M. Airborne Aspergillus fumigatus spore concentration during demolition of a building on a hospital area and patient risk determination for invasive aspergillosis including azole resistance. J. Hosp. Infect. 2018, 100, e91–e97. [Google Scholar] [CrossRef] [PubMed]
- Park, J.H.; Ryu, S.H.; Lee, J.Y.; Kim, H.J.; Kwak, S.H.; Jung, J.; Lee, J.; Sung, H.; Kim, S.H. Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: A prospective cohort study. Antimicrob. Resist. Infect. Control 2019, 8, 88. [Google Scholar] [CrossRef]
- Boan, P.; Pang, S.; Gardam, D.J.; Darragh, H.; Wright, M.; Coombs, G.W. Investigation of a Lomentospora prolificans case cluster with whole genome sequencing. Med. Mycol. Case Rep. 2020, 29, 1–4. [Google Scholar] [CrossRef] [PubMed]
- Le Clech, L.; Uguen, M.; Quinio, D.; Nevez, G.; Couturier, M.A.; Ianotto, J.C.; Berthou, C.; Guillerm, G.; Le Bars, H.; Payan, C.; et al. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia. Curr. Res. Transl. Med. 2020, 68, 23–28. [Google Scholar] [CrossRef]
- Atilla, A.; Çelik, M.; Çolak, Ö.Y.; Kuruoğlu, T.; Temoçin, F.; Kelkitli, E.; Birinci, A. Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors. Mikrobiyol. Bul. 2022, 56, 315–325. [Google Scholar] [CrossRef]
- Sathitakorn, O.; Chaononghin, S.; Katawethiwong, P.; Pientong, T.; Weber, D.J.; Warren, D.K.; Apisarnthanarak, P.; Apisarnthanarak, A. Strategies to limit invasive fungal infection in a coronavirus disease 2019 (COVID-19) intensive care unit: The role of infection prevention for renovation and construction in resource-limited settings. Antimicrob. Steward. Healthc. Epidemiol. 2022, 2, e74. [Google Scholar] [CrossRef]
- Bartoletti, M.; Pascale, R.; Cricca, M.; Rinaldi, M.; Maccaro, A.; Bussini, L.; Fornaro, G.; Tonetti, T.; Pizzilli, G.; Francalanci, E.; et al. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Clin. Infect. Dis. 2021, 73, e3606–e3614. [Google Scholar] [CrossRef] [PubMed]
- Tio, S.Y.; Williams, E.; Worth, L.J.; Deane, A.M.; Bond, K.; Slavin, M.A.; Sasadeusz, J. Invasive pulmonary aspergillosis in critically ill patients with COVID-19 in Australia: Implications for screening and treatment. Intern. Med. J. 2021, 51, 2129–2132. [Google Scholar] [CrossRef]
- Lass-Flörl, C.; Cuenca-Estrella, M. Changes in the epidemiological landscape of invasive mould infections and disease. J. Antimicrob. Chemother. 2017, 72, i5–i11. [Google Scholar] [CrossRef] [PubMed]
- Verweij, P.E.; Rijnders, B.J.A.; Brüggemann, R.J.M.; Azoulay, E.; Bassetti, M.; Blot, S.; Calandra, T.; Clancy, C.J.; Cornely, O.A.; Chiller, T.; et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: An expert opinion. Intensive Care Med. 2020, 46, 1524–1535. [Google Scholar] [CrossRef]
- Liu, S.; Li, Z.; Zheng, J.; He, N. Invasive Aspergillus outbreak in inhalation injury: A case presentation and literature review. BMC Infect. Dis. 2022, 22, 386. [Google Scholar] [CrossRef]
- Clair, J.D.; Colatrella, S. Opening Pandora’s (tool) Box: Health care construction and associated risk for nosocomial infection. Infect. Disord. Drug Targets 2013, 13, 177–183. [Google Scholar] [CrossRef]
- Cheng, V.C.; Lo, W.K.; Woo, P.C.; Chan, S.B.; Cheng, S.W.; Ho, M.; Yuen, K.Y. Polymicrobial outbreak of intermittent peritoneal dialysis peritonitis during external wall renovation at a dialysis center. Perit. Dial. Int. 2001, 21, 296–301. [Google Scholar] [CrossRef] [PubMed]
- Guidelines for Design and Construction of Hospital and Healthcare Facilities updated July 2019. Available online: https://www.fgiguidelines.org/wp-content/uploads/2016/11/1996-97guidelines.pdf (accessed on 3 December 2022).
- Centers for Disease Control and Prevention. Guidelines for environmental infection control in health-care facilities: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm. Rep. 2003, 52, 1–48. [Google Scholar]
- ASHE’s Infection Control Risk Assessment 2.0. Matrix of Precautions for Construction, Renovation and Operations. Available online: https://www.ashe.org/ashe-publishes-updated-infection-control-risk-assessment (accessed on 3 December 2022).
- Talento, A.F.; Fitzgerald, M.; Redington, B.; O’Sullivan, N.; Fenelon, L.; Rogers, T.R. Prevention of healthcare-associated invasive aspergillosis during hospital construction/renovation works. J. Hosp. Infect. 2019, 103, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Bouza, E.; Peláez, T.; Pérez-Molina, J.; Marín, M.; Alcalá, L.; Padilla, B.; Muñoz, P.; Adán, P.; Bové, B.; Bueno, M.J.; et al. Aspergillus Study Team. Demolition of a hospital building by controlled explosion: The impact on filamentous fungal load in internal and external air. J. Hosp. Infect. 2002, 52, 234–242. [Google Scholar] [CrossRef]
- Chang, C.C.; Cheng, A.C.; Devitt, B.; Hughes, A.J.; Campbell, P.; Styles, K.; Low, J.; Athan, E. Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works. J. Hosp. Infect. 2008, 69, 33–38. [Google Scholar] [CrossRef]
- Ullmann, A.J.; Aguado, J.M.; Arikan-Akdagli, S.; Denning, D.W.; Groll, A.H.; Lagrou, K.; Lass-Flörl, C.; Lewis, R.E.; Munoz, P.; Verweij, P.E.; et al. Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin. Microbiol. Infect. 2018, 24, e1–e38. [Google Scholar] [CrossRef] [Green Version]
- Sherertz, R.J.; Belani, A.; Kramer, B.S.; Elfenbein, G.J.; Weiner, R.S.; Sullivan, M.L.; Thomas, R.G.; Samsa, G.P. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am. J. Med. 1987, 83, 709–718. [Google Scholar] [CrossRef] [PubMed]
- Cornet, M.; Levy, V.; Fleury, L.; Lortholary, J.; Barquins, S.; Coureul, M.H.; Deliere, E.; Zittoun, R.; Brücker, G.; Bouvet, A. Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect. Control. Hosp. Epidemiol. 1999, 20, 508–513. [Google Scholar] [CrossRef] [PubMed]
- Passweg, J.R.; Rowlings, P.A.; Atkinson, K.A.; Barrett, A.J.; Gale, R.P.; Gratwohl, A.; Jacobsen, N.; Klein, J.P.; Ljungman, P.; Russell, J.A.; et al. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone. Marrow. Transplant. 1998, 21, 1231–1238. [Google Scholar] [CrossRef] [Green Version]
- Hahn, T.; Cummings, K.M.; Michalek, A.M.; Lipman, B.J.; Segal, B.H.; McCarthy, P.L., Jr. Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect. Control Hosp. Epidemiol. 2002, 23, 525–531. [Google Scholar] [CrossRef] [PubMed]
- Oren, I.; Haddad, N.; Finkelstein, R.; Rowe, J.M. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: Before and after chemoprophylaxis and institution of HEPA filters. Am. J. Hematol. 2001, 66, 257–262. [Google Scholar] [CrossRef]
- Vokurka, S.; Bystrická, E.; Svoboda, T.; Škoda Gorican, I.K.; Sever, M.; Mazur, E.; Kopinska, A.; Pavlicová, V.; Mocanu, O.; Tanase, A.; et al. The availability of HEPA-filtered rooms and the incidence of pneumonia in patients after haematopoietic stem cell transplantation (HSCT): Results from a prospective, multicentre, eastern European study. J. Clin. Nurs. 2014, 23, 1648–1652. [Google Scholar] [CrossRef]
- Tomblyn, M.; Chiller, T.; Einsele, H.; Gress, R.; Sepkowitz, K.; Storek, J.; Wingard, J.R.; Young, J.A.; Boeckh, M.J.; Center for International Blood and Marrow Research; et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: A global perspective. Biol. Blood. Marrow. Transplant. 2009, 15, 1143–1238. [Google Scholar] [CrossRef] [Green Version]
- Tablan, O.C.; Anderson, L.J.; Besser, R.; Bridges, C.; Hajjeh, R. Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care--associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm. Rep. 2004, 53, 1–36. [Google Scholar]
- Eckmanns, T.; Rüden, H.; Gastmeier, P. The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: A systematic review. J. Infect. Dis. 2006, 193, 1408–1418. [Google Scholar] [CrossRef] [Green Version]
- Tsai, C.K.; Yeh, C.M.; Hong, Y.C.; Chen, P.M.; Liu, J.H.; Gau, J.P.; Liu, C.J. The influence of high-efficiency particulate air filtration on mortality among multiple myeloma patients receiving autologous stem cell transplantation. Sci. Rep. 2021, 11, 11789. [Google Scholar] [CrossRef]
- Gómez-Almaguer, D.; Gómez-De León, A.; Colunga-Pedraza, P.R.; Cantú-Rodríguez, O.G.; Gutierrez-Aguirre, C.H.; Ruíz-Arguelles, G. Outpatient allogeneic hematopoietic stem-cell transplantation: A review. Ther. Adv. Hematol. 2022, 26, 20406207221080739. [Google Scholar] [CrossRef] [PubMed]
- Ringdén, O.; Remberger, M.; Törlén, J.; Engström, M.; Fjaertoft, G.; Mattsson, J.; Svahn, B.M. Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital. Pediatr. Transplant. 2014, 18, 398–404. [Google Scholar] [CrossRef] [PubMed]
- Ruiz-Argüelles, G.J.; Seber, A.; Ruiz-Delgado, G.J. Conducting hematopoietic stem cell transplantation in low and middle income countries. Hematology 2022, 27, 809–812. [Google Scholar] [CrossRef] [PubMed]
- Styczynski, J.; Tridello, G.; Donnelly, J.P.; Iacobelli, S.; Hoek, J.; Mikulska, M.; Aljurf, M.; Gil, L.; Cesaro, S. Protective environment for hematopoietic cell transplant (HSCT) recipients: The Infectious Diseases Working Party EBMT analysis of global recommendations on health-care facilities. Bone Marrow Transplant. 2018, 53, 1131–1138. [Google Scholar] [CrossRef] [Green Version]
- Nihtinen, A.; Anttila, V.J.; Richardson, M.; Meri, T.; Volin, L.; Ruutu, T. The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration. Bone Marrow. Transplant. 2007, 40, 457–460. [Google Scholar] [CrossRef] [Green Version]
- Salam, Z.H.A.; Karlin, R.B.; Ling, M.L.; Yang, K.S. The impact of portable high-efficiency particulate air filters on the incidence of invasive aspergillosis in a large acute tertiary-care hospital. Am. J. Infect. Control 2010, 38, e1–e7. [Google Scholar] [CrossRef]
- Belizario, J.A.; Lopes, L.G.; Pires, R.H. Fungi in the indoor air of critical hospital areas: A review. Aerobiologia 2021, 37, 79–394. [Google Scholar] [CrossRef]
- Thio, C.L.; Smith, D.; Merz, W.G.; Streifel, A.J.; Bova, G.; Gay, L.; Miller, C.B.; Perl, T.M. Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect. Control Hosp. Epidemiol. 2000, 21, 18–23. [Google Scholar] [CrossRef] [PubMed]
- Jo, J.L.; Lee, J.Y.; Kim, H.J.; Lim, S.Y.; Lim, Y.J.; Kim, E.O.; Jung, J.; Kim, S.H. Evaluation of indoor airborne fungal concentration in haematologic wards over a two-year period. J. Hosp. Infect. 2022, 127, 129–130. [Google Scholar] [CrossRef]
- Martinez-Bracero, M.; Markey, E.; Clancy, J.H.; McGillicuddy, E.J.; Sewell, G.; O’Connor, D.J. Airborne Fungal Spore Review, New Advances and Automatisation. Atmosphere 2022, 13, 308. [Google Scholar] [CrossRef]
- Kilburg-Basnyat, B.; Metwali, N.; Thorne, P.S. Performance of electrostatic dust collectors (EDCs) for endotoxin assessment in homes: Effect of mailing, placement, heating, and electrostatic charge. J. Occup. Environ. Hyg. 2016, 13, 85–93. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Viegas, C.; Faria, T.; Dos Santos, M.; Carolino, E.; Sabino, R.; Quintal Gomes, A.; Viegas, S. Slaughterhouses Fungal Burden Assessment: A Contribution for the Pursuit of a Better Assessment Strategy. Int. J. Environ. Res. Public Health 2016, 13, 297. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Viegas, C.; Santos, P.; Almeida, B.; Monteiro, A.; Carolino, E.; Quintal Gomes, A.; Vviegas, S. Electrostatic dust collector: A passive screening methods to assess occupational exposure to organic dust in primary healthcare center. Air. Qual. Atmos. Health 2019, 12, 573–583. [Google Scholar] [CrossRef]
- Normand, A.C.; Ranque, S.; Cassagne, C.; Gaudart, J.; Sallah, K.; Charpin, D.A.; Piarroux, R. Comparison of Air Impaction and Electrostatic Dust Collector Sampling Methods to Assess Airborne Fungal Contamination in Public Buildings. Ann. Occup. Hyg. 2016, 60, 161–175. [Google Scholar] [CrossRef] [PubMed]
- Pilmis, B.; Thepot-Seegers, V.; Angebault, C.; Weiss, E.; Alaabouche, I.; Bougnoux, M.E.; Zahar, J.R. Could we predict airborne Aspergillus contamination during construction work? Am. J. Infect. Control 2017, 45, 39–41. [Google Scholar] [CrossRef]
- van Rhijn, N.; Coleman, J.; Collier, L.; Moore, C.; Richardson, M.D.; Bright-Thomas, R.J.; Jones, A.M. Meteorological Factors Influence the Presence of Fungi in the Air; A 14-Month Surveillance Study at an Adult Cystic Fibrosis Center. Front Cell Infect. Microbiol. 2021, 11, 759944. [Google Scholar] [CrossRef]
- Mori, T.; Kikuchi, T.; Kato, J.; Koda, Y.; Sakurai, M.; Kikumi, O.; Inose, R.; Murata, M.; Hasegawa, N.; Nakayama, H.; et al. Seasonal changes in indoor airborne fungal concentration in a hematology ward. J. Infect. Chemother. 2020, 26, 363–366. [Google Scholar] [CrossRef]
- Sautour, M.; Sixt, N.; Dalle, F.; L’Ollivier, C.; Fourquenet, V.; Calinon, C.; Paul, K.; Valvin, S.; Maurel, A.; Aho, S.; et al. Profiles and seasonal distribution of airborne fungi in indoor and outdoor environments at a French hospital. Sci. Total. Environ. 2009, 407, 3766–3771. [Google Scholar] [CrossRef]
- Li, L.; Ma, J.; Yang, K.; Chai, F.; Liu, J.; Guo, X. Microbial aerosol particles in four seasons of sanitary landfill site: Molecular approaches, traceability and risk assessment. J. Environ. Sci. 2021, 108, 120–133. [Google Scholar] [CrossRef]
- González-Garcia, P.; Alonso-Sardón, M.; López-Bernus, A.; Carbonell, C.; Romero-Alegría, Á.; Muro, A.; Galindo-Pérez, I.; Muñoz-Bellido, J.; Pardo-Lledias, J.; Belhassen-García, M. Epidemiology of aspergillosis in hospitalised Spanish patients-A 21-year retrospective study. Mycoses 2021, 64, 520–527. [Google Scholar] [CrossRef]
- Qian, Y.; Willeke, K.; Grinshpun, S.A.; Donnelly, J.; Coffey, C.C. Performance of N95 respirators: Filtration efficiency for airborne microbial and inert particles. Am. Ind. Hyg. Assoc. J. 1998, 59, 128–132. [Google Scholar] [CrossRef] [PubMed]
- Maschmeyer, G.; Neuburger, S.; Fritz, L.; Böhme, A.; Penack, O.; Schwerdtfeger, R.; Buchheidt, D.; Ludwig, W.D.; Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology. A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients. Ann. Oncol. 2009, 20, 1560–1564. [Google Scholar] [CrossRef]
- Patterson, T.F.; Thompson, G.R., 3rd; Denning, D.W.; Fishman, J.A.; Hadley, S.; Herbrecht, R.; Kontoyiannis, D.P.; Marr, K.A.; Morrison, V.A.; Nguyen, M.H.; et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2016, 63, e1–e60. [Google Scholar] [CrossRef] [PubMed]
- Combariza, J.F.; Toro, L.F.; Orozco, J.J.; Arango, M. Cost-effectiveness analysis of interventions for prevention of invasive aspergillosis among leukemia patients during hospital construction activities. Eur. J. Haematol. 2018, 100, 140–146. [Google Scholar] [CrossRef] [PubMed]
- Chabrol, A.; Cuzin, L.; Huguet, F.; Alvarez, M.; Verdeil, X.; Linas, M.D.; Cassaing, S.; Giron, J.; Tetu, L.; Attal, M.; et al. Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia. Haematologica 2010, 95, 996–1003. [Google Scholar] [CrossRef]
- National Guidelines for the Prevention of Nosocomial Aspergillosis. A Report of the Aspergillosis Subcommittee of the Health Protection Surveillance Centre Scientific Advisory Committee. 2018. Available online: https://www.hpsc.ie/a-z/microbiologyantimicrobialresistance/infectioncontrolandhai/guidelines/Aspergillus%20Guidelines%202018.pdf (accessed on 14 January 2023).
Author, Year | Patient Population | No. of Patients Infected | No. of Patient Deaths | Type of Infection (Site) | Type of Fungi | Reservoir or Source | Molecular Typing | Control Measures |
---|---|---|---|---|---|---|---|---|
Barreiros, G. et al., 2015 [29] | Patients divided into three risk groups: the highest—acute leukemia, HCT recipients; intermediate—HIV in advanced stage, high dose corticosteroids therapy, SOT recipients; low—all other patients | Incidence of IA (cases per 1000 admissions): 0.9 in the 12 months before demolition, 0.4 during demolition; and 0.5 in the 12 months after implosion | not specified | Invasive aspergillosis (sites not specified) | not specified | Mechanical demolition to detach the two wings and implosion | not performed | Permanent humidification, limitation of circulation of people in areas close to demolition, sealing of the windows, increase in environmental cleaning, staff education, rooms with HEPA filters for highest risk patients, high risk patients used N95 masks when circulated in non-protected areas |
Gheith, S. et al., 2015 [30] | Hematologic malignancies (AML, ALL); patients with a profound postchemotherapy neutropenia were included | 11 | not specified | Invasive aspergillosis (lung) except one patient with invasive ethmoditis with periorbital expansion and without prior lung involvement | A. niger species complex, A. flavus species complex, A. nidulans species complex, A. fumigatus species complex | Airborne contamination was a significant and independent IA risk factor in the renovation work setting | not performed | Air treatment systems and aspergillosis control measures were lacking in the hospital |
Loschi, M. et al., 2015 [31] | Hematologic malignancies (AML, ALL, NHL, HL, multiple myeloma, MDS, CLL) | 102 | 8 | Invasive pulmonary aspergillosis except one disseminated with cerebral lesions | unknown | Five years of indoor and outdoor renovations, including excavations, collapsing of walls, sanding, and wiring | not performed | Air lock chambers between hospitalization units and building sites’ adhesive carpets for collecting dust, surgical masks required for neutropenic patients when leaving their rooms, windows were sealed, pedestrian traffic rearranged |
Özen, M. et al., 2016 [32] | Hematologic malignancies (AML, ALL) | 29 | not specified | Invasive fungal infections (site of infections not described) | unknown | Source of infection was not revealed; large-scale construction taking place near the hematology clinic probable source of infection | not performed | Portable HEPA filters were installed in patients’ rooms |
Combariza, J. et al., 2017 [33] | Hematologic malignancies (AML, ALL) | 29 | not specified | Invasive aspergillosis (site of infections not defined) | unknown | Outbreak was associated with an extensive building work | not performed | Dust control procedures (cleaning, sealing of rooms), plastic barriers, redirection of traffic, HEPA filters and positive pressure, FFP2 masks for patients when going near construction area, prophylaxis with posaconazole |
Kabbani, D. et al., 2018 [34] | Heart transplant recipients | 7 | 3 (in one patient non-IA-related death and in one patient IA- and mucormycosis-related death) | Invasive aspergillosis (lung) | A. fumigatus species complex | Air and environmental sampling failed to reveal source of infection; the construction around the hospital might have played a role | not performed | Screening chest CT scans; all new HTRs antifungal prophylaxis with micafungin intravenously daily during hospitalization, followed by inhaled amphotericin 20 mg twice a day for 3 months |
Wirmann, L. et al., 2018 [35] | Immunocompromised patients (hematologic malignancies, solid organ transplant recipients) | 44 | not specified | Invasive aspergillosis | not specified | Extensive demolition works | Genotyping by microsatellite PCR of the azole-resistant environmental and clinical isolates showed a polyclonal distribution | Water jets to suppress dust emission, all windows facing the demolition site closed; immunocompromised patients leaving the protective area were equipped with high-efficiency filtration face masks; patients undergoing bone marrow transplantation are located in rooms protected by high-efficiency particulate air (HEPA) filters and positive pressure |
Park, J.H. et al., 2019 [36] | Hematologic malignancies (AML the most common) | 29 | 8 | Two patients with invasive aspergillus sinusitis and remaining patients with invasive pulmonary aspergillosis | A. fumigatus species complex, A. flavus species complex, A. niger species complex | Radiotherapy facility construction | not performed | HEPA filters and positive pressure ventilation systems |
Boan, P. et al., 2020 [37] | Hematologic malignancies (AlloHCT, CLL, AML) | 4 | 4 | Soft tissue and disseminated infections | Lomentospora prolificans | Environmental source was not found; minor earthworks adjacent to the hospital and water leakage from plumbing at a distant part of the hospital are mentioned | WGS suggested the infections were not caused by a single strain | no change in practice |
Le Clech, L. et al., 2020 [38] | Hematologic malignancies (AML) | 8 | not specified (one-year survival for patients with IA was 60%) | Invasive pulmonary aspergillosis | not specified | Air samples revealed A. fumigatus species complex and A. versicolor species complex; periods of hospital construction, renovation and demolition near the Department of Clinical Hematology | not performed | HEPA filters |
Atilla, A. et al., 2022 [39] | Hematologic malignancies (AML, lymphoma, ALL, MDS, multiple myeloma) | 412 patients with invasive fungal infection and 145 patients with invasive mold infection | 136 (28-day mortality 33.0%) | Invasive aspergillosis (lung), mucormycosis, and invasive candidosis (blood culture) | A. flavus species complex, A. fumigatus species complex, A. terreus species complex, Mucor spp. | Source of infection was not revealed; proximity of construction site probable source of infection | not performed | Relocation of patients to the new hospital building |
Sathitakorn, O. et al., 2022 [40] | COVID−19 ICU patients | 4 | 4 | Invasive pulmonary aspergillosis | A. flavus species complex, A. fumigatus species complex | Renovation and construction activity near the ICU (demolition work including removing the floor covering, ceiling tiles, case work, and new wall construction on the same floor) | not performed | Site containment, installation of critical barriers to seal construction areas from clinical areas, cleaning of construction areas, use negative air-pressure handling of the construction site using exhaust fans, and installing portable HEPA filters at the construction site |
Author, Year | Air Samples Collection | Environmental Samples Collection | Fungal Identification | Airborne Total Fungal Level | Airborne Specific Fungal Level | Environmental Samples Results |
---|---|---|---|---|---|---|
Barreiros, G. et al., 2015 [29] | Using a 6-stage Andersen air sampler (Andersen: Thermo Fisher Scientific, Inc. Waltham, MA, USA) which collects air at a rate of 28.3 L/min; each stage of the air sampler was filled with 90 × 15 mm plates containing 2% Sabouraud dextrose agar (DIFCO, Houston, TX, USA) with gentamycin (200 ug/mL). The samples were performed during 30 min in indoor areas and 5 min in outdoor areas. After sampling, the plates were incubated at 25 °C for at least 7 days. | not performed | Colony counts were performed weekly, and subcultures were made using potato dextrose agar (DIFCO), Czapek agar (DIFCO), lactrimel agar, oat agar, and malt extract agar. Identification of fungi was performed on the basis of morphological parameters, initially by observing the characteristics of colonies in a stereoscopic microscope. Subcultures were performed if the colonies had the characteristics consistent with clinically relevant fungi (Aspergillus, Fusarium, agents of mucormycosis, as well as Cladosporium and Penicillium). The most frequent species was A. niger complex. | The concentration increased with values of 148.17 CFU/m3 in the historical period, 271.45 CFU/m3 during demolition, 1887.67 CFU/m3 on the day of implosion and 204.10 CFU/m3 in the postimplosion period. | Concentration of Aspergillus spp. varied significantly: 3.71 CFU/m3 in the historical period, 7.18 CFU/m3 in the demolition period, 22.5 CFU/m3 on the day of implosion, and 15.13 CFU/m3 of air in the postimplosion period. The mean concentration of agents of mucormycosis was low in all periods (0.2 CFU/m3 in the historical period, zero in the periods of mechanical demolition and implosion, and 0.1 CFU/m3 in the postimplosion period. Dematiaceous fungi other than Cladosporium spp. were encountered in small amounts (mean 3.45/m3). | N/A |
Gheith, S. et al., 2015 [30] | Air samples were collected at 100 cm from the patient’s bed and at 50 cm from the room entrance by using a Microflow portable air sampler (Aquaria Srl, Lacchiarella, Italy) that aspirates and inoculates airborne spores through a sampling grid onto the Sabouraud chloramphenicol medium. | Surface samples were collected by the swabbing with a moist cotton swab of 25 cm2 of each of the following surfaces: bed, window, curtain, door wrist, nightstand, table, and cupboard. Each sample was inoculated onto the Sabouraud–chloramphenicol medium (Bio-Rad). | Fungal colonies were identified and counted after a 5-day incubation at 27 °C. The identification of the filamentous fungi was based on both the macroscopic and microscopic characteristics of the colonies. Aspergilli were identified to the section level because morphological differentiation of species within the same section is questionable in a routine laboratory setting. Colony-forming units (CFU) were expressed per m2 and per m3 in surface and air samples, respectively. | In air samples, the total fungal contamination (CFUs) significantly correlated with Aspergillus spp., Aspergillus section Nigri and Aspergillus section flavi. | Aspergillus spp. CFU counts in air samples during 14 months of renovation was higher (8.1 vs 6 mean CFU/m3, p = 0.031) than during the period after work stopped. | The same pattern was observed (12.34 vs 6.8 mean CFU/m3, p = 0.00002) regarding Aspergillus CFU counts in surface samples. |
Loschi, M. et al., 2015 [31] | Airborne Aspergillus concentrations were measured weekly by repeated air sampling in each department. Areas with positive samples were retested after corrective measures. Samples were collected using a Reuter Centrifugal Impaction (RCS) High Flow Air Center (Biotest Hycon, Germany) loaded with ready-to-use culture media on flexible agar strips with modified Sabouraud dextrose agar for yeast and molds, γ-irradiated in double wrapper to determine the total number of fungal spores in the air (Biotest Hycon, Germany). | not performed | When the cultures were positive, colonies were quantified as colony-forming units (CFU) per cubic meter (m3). Less than 20 CFU/m3 was considered acceptable in all areas except for ICU where 0 CFU/m3 was required. | not performed (only Aspergillus concentrations were measured) | Airborne spore levels ranged from 0 to 30 CFU/m3. There was an increased number of positive samples in the standard unit compared to the ICU (p < 0.0001). | N/A |
Özen, M. et al., 2016 [32] | The level of airborne particulates in patients’ rooms to evaluate HEPA filter efficiency was randomly measured; the methods was not specified. | not performed | not specified | The levels of particulates in the patients’ rooms were within acceptable limits; the results were not specified. | not specified | N/A |
Combariza, J. et al., 2017 [33] | not performed | not performed | N/A | N/A | N/A | N/A |
Kabbani, D. et al., 2018 [34] | not specified | not specified | not specified | not specified; air sampling of potential common pre- and post-admission exposure links during this outbreak failed to reveal a common environmental source of infection. | not specified | not specified; environmental sampling of potential common pre- and post-admission exposure links during this outbreak failed to reveal a common environmental source of infection. |
Wirmann, L. et al., 2018 [35] | The measuring apparatus MAS−100 (Merck Chemicals GmbH, Darmstadt, Germany) was used. The apparatus was placed 1m above ground level. For each sample, 500 L of air was collected on malt extract agar plates. The measuring head of MAS−100 was autoclaved between each sampling day. The agar plates were incubated at 50 °C for 48 h. | not performed | Samples that showed visible mold growth after the incubation period were examined microscopically to identify A. fumigatus. All A. fumigatus isolates were plated on to Sabouraud dextrose agar containing 4mg/L itraconazole to screen for azole resistance. Grown isolates were subjected to antifungal susceptibility testing for itraconazole, voriconazole, posaconazole, and isavuconazole, according to EUCAST standard 9.3. The cyp51A gene was sequenced for all isolates with elevated minimum inhibitory concentration against an azole, as described recently. All colonies identified microscopically as A. fumigatus were counted and documented as colony-forming units (CFU)/m3. Additionally, the number of colonies was corrected according to Feller. | not performed (only Aspergillus spp. concentrations were measured) | Mean concentrations of A. fumigatus spores did not differ significantly be-tween the three periods before (17.5 CFU/m³), during 30 (20.8 CFU/m³) (p = 0.26), and after demolition (17.7 CFU/m³) (p = 0.33). | N/A |
Park, J.H. et al., 2019 [36] | Air sampling was conducted once a month in the three hematologic wards during the construction period. A total of 1000 L of air was collected three times every 20 min by using a portable air sampler (AirPort MD8, Sartorius AG, Germany) located at each nurse station. Air was plated onto Sabouraud dextrose agar and incubated at 30 °C for five days. | not performed | After incubation, colonies were counted, and the data expressed as median colony-forming units (CFU) per 1000 L of air. Colonies were identified at the genus level based on macroscopic and microscopic findings (lactophenol cotton blue-stained preparation). | The total mold spore level tended to be lower in period 2 (5.60 CFU/1000 L) with lighter works such as framing, interior designing, plumbing, and finishing in comparison to period 1 (9.95 CFU/1000 L) with heavier works such as demolition and excavation. | Aspergillus spore levels were also lower in period 2 (1.70 CFU/1000 L) than in period 1 (2.35 CFU/1000 L). | N/A |
Boan, P. et al., 2020 [37] | One cubic meter of air for fungal culture was sampled in affected patients’ rooms, other areas of the hematology wards, the cancer outpatient center, the main hospital concourse, car park, and open grounds. | Swabs for fungal culture were taken from patient sinks and various other surfaces of patients’ rooms in the hematology wards. | not specified | not specified | Lomontospora prolificanswas was not found in air samples. | Lomontospora prolificans was not found in environmental samples. |
Le Clech, L. et al., 2020 [38] | Air sampling was conducted with the MAS−100 biocollector (Merck, Darmstadt, Germany) using Sabouraud chloramphenicol plates. | Surface samples were collected using a biocontact applicator (Oxoid, Dardilly, France). | not specified | not specified (results were presented as percentage of positive samples) | A. fumigatus species complex and A. versicolor species complex were detected; level not specified (results were presented as a percentage of positive samples). | A. fumigatus species complex and A. versicolor species complex were detected; level not specified (results were presented as a percentage of positive samples). |
Atilla, A. et al., 2022 [39] | not performed | not performed | N/A | N/A | N/A | N/A |
Sathitakorn, O. et al., 2022 [40] | not specified | not performed | not specified | At the front of ICU, the nursing station, the index patient anterooms, and rooms, airborne fungal bioburdens from air sampling were 235–290 CFU/m3 at all sites; the baseline standard airborne fungal bioburden was <150 CFU/m3 for the ICU. | not specified | N/A |
Construction Type | ||||
---|---|---|---|---|
Patient Risk Group | Type A | Type B | Type C | Type D |
Low risk group | I | II | II | III |
Medium risk group | I | II | III | IV |
High risk group | I | III | IV | V |
Highest risk group | III | IV | V | V |
Unit Below: | Unit Above: | Unit Lateral: | Unit Behind: | Unit in Front: |
Risk Group: | Risk Group: | Risk Group: | Risk Group: | Risk Group: |
Contact: | Contact: | Contact: | Contact: | Contact: |
Phone: | Phone: | Phone: | Phone: | Phone: |
Additional Controls: ▫ noise▫ vibration ▫ dust control ▫ ventilation ▫ pressurization ▫ vertical shafts ▫ elevators/stairs Systems impacted: ▫ data ▫ mechanical ▫ med. gases ▫ hot/cold water | Additional Controls: ▫ noise ▫ vibration ▫ dust control ▫ ventilation ▫ pressurization ▫ vertical shafts ▫ elevators/stairs Systems impacted: ▫ data ▫ mechanical ▫ med. gases ▫ hot/cold water | Additional Controls: ▫ noise ▫ vibration ▫ dust control ▫ ventilation ▫ pressurization ▫ vertical shafts ▫ elevators/stairs Systems impacted: ▫ data ▫ mechanical ▫ med. gases ▫ hot/cold water | Additional Controls: ▫ noise ▫ vibration ▫ dust control ▫ ventilation ▫ pressurization ▫ vertical shafts ▫ elevators/stairs Systems impacted: ▫ data ▫ mechanical ▫ med. gases ▫ hot/cold water | Additional Controls: ▫ noise ▫ vibration ▫ dust control ▫ ventilation ▫ pressurization ▫ vertical shafts ▫ elevators/stairs Systems impacted: ▫ data ▫ mechanical ▫ med. gases ▫ hot/cold water |
Precaution Class | Mitigation Activities |
---|---|
I | 1. Perform noninvasive work activity as to not block or interrupt patient care. 2. Perform noninvasive work activities in areas that are not directly occupied with patients. 3. Perform noninvasive work activity in a manner that does not create dust. 4. Immediately replace any displaced ceiling tile before leaving the area and/or at end of noninvasive work activity. |
II | 1. Perform only limited dust work and/or activities designed for basic facilities and engineering work. 2. Perform limited dust and invasive work following standing precaution procedures approved by the organization. 3. This class of precautions must never be used for construction or renovation activities. |
III | 1. Provide active means to prevent airborne dust dispersion into the occupied areas. 2. Means for controlling minimal dust dispersion may include hand-held HEPA vacuum devices, polyethylene plastic containment, or isolation of work area by closing room door. 3. Remove or isolate return air diffusers to avoid dust from entering the HVAC system. 4. Remove or isolate the supply air diffusers to avoid positive pressurization of the space. 5. If work area is contained, then it must be neutrally to negatively pressurized at all times. 6. Seal all doors with tape that will not leave residue. 7. Contain all trash and debris in the work area. 8. Nonporous/smooth and cleanable containers (with a hard lid) must be used to transport trash and debris from the construction areas. These containers must be damp wipe cleaned and free of visible dust/debris before leaving the contained work area. 9. Install an adhesive (dust collection) mat at entrance of contained work area based on facility policy. Adhesive mats must be changed routinely and when visibly soiled. 10. Maintain clean surroundings when area is not contained by damp mopping or HEPA vacuuming surfaces. |
IV | 1. Construct and complete critical barriers meeting NFPA 241 requirements including: barriers must extend to the ceiling or, if ceiling tile is removed, to the deck above, and all penetrations through the barrier shall meet the appropriate fire rating requirements. 2. All (plastic or hard) barrier construction activities must be completed in a manner that prevents dust release. Plastic barriers must be effectively affixed to the ground and ceiling and secure from movement or damage. Apply tape that will not leave a residue to seal gaps between barriers, ceiling, or floor. 3. Seal all penetrations in containment barriers, including floors and ceiling, using approved materials (UL schedule firestop if applicable for barrier type). 4. Containment units or environmental containment units (ECUs) approved for Class IV precautions in small areas totally contained by the unit and that have HEPA-filtered exhaust air. 5. Remove or isolate return air diffusers to avoid dust entering the HVAC system. 6. Remove or isolate the supply air diffusers to avoid positive pressurization of the space. 7. Negative airflow pattern must be maintained from the entry point to the anteroom and into the construction area. The airflow must cascade from outside to inside the construction area. The entire construction area must remain negatively pressurized. 8. Maintain negative pressurization of the entire workspace by use of HEPA exhaust air systems directed outdoors. Exhaust discharged directly to the outdoors that is 25 feet or greater from entrances, air intakes, and windows does not require HEPA-filtered air. 9. If exhaust is directed indoors, then the system must be HEPA filtered. Prior to start of work, HEPA filtration must be verified by particulate measurement at no less than 99.97% efficiency and must not alter or change airflow/pressure relationships in other areas. 10. Exhaust into shared or recirculating HVAC systems, or other shared exhaust systems (e.g., bathroom exhaust) is not acceptable. 11. Install device on exterior of work containment to continually monitor negative pressurization. To assure proper pressure is continuously maintained, it is recommended that the device(s) has (have) a visual pressure indicator. 12. Contain all trash and debris in the work area. 13. Nonporous/smooth and cleanable containers (with a hard lid) must be used to transport trash and debris from the construction areas. These containers must be damp wipe cleaned and free of visible dust/debris before leaving the contained work area. 14. Worker clothing must be clean and free of visible dust before leaving the work area. HEPA vacuuming of clothing or use of cover suits is acceptable. 15. Workers must wear shoe covers prior to entry into the work area. Shoe covers must be changed prior to exiting the anteroom to the occupied space (non-work area). Damaged shoe covers must be immediately changed. 16. Install an adhesive (dust collection) mat at the entrance of the contained work area based on facility policy. Adhesive mats must be changed routinely and when visibly soiled. 17. Consider collection of particulate data during work to monitor and ensure that contaminates do not enter the occupied spaces. Routine collection of particulate samples may be used to verify HEPA filtration efficiencies. |
V | 1. Construct and complete critical barriers meeting NFPA 241 requirements including: barriers must extend to the ceiling, or if ceiling tile is removed, to the deck above, and all penetrations through the barrier shall meet the appropriate fire rating requirements. 2. All (plastic or hard) barrier construction activities must be completed in a manner that prevents dust release. Plastic barriers must be effectively affixed to the ground and ceiling and secure from movement or damage. Apply tape that will not leave a residue to seal gaps between barriers, ceiling, or floor. 3. Seal all penetrations in containment barriers, anteroom barriers, including floors and ceiling using approved materials (UL schedule firestop if applicable for barrier type). 4. Construct anteroom large enough for equipment staging, cart cleaning, and workers. The anteroom must be constructed adjacent to the entrance of the construction work area. 5. Personnel will be required to wear disposable coveralls at all times during Class V work activities. Disposable coveralls must be removed before leaving the anteroom. 6. Remove or isolate return air diffusers to avoid dust entering the HVAC system. 7. Remove or isolate the supply air diffusers to avoid positive pressurization of the space. 8. Negative airflow pattern must be maintained from the entry point to the anteroom and into the construction area. The airflow must cascade from outside to inside the construction area. The entire construction area must remain negatively pressurized. 9. Maintain negative pressurization of the entire workspace using HEPA exhaust air systems directed outdoors. Exhaust discharged directly to the outdoors that is 25 feet or greater from entrances, air intakes, and windows does not require HEPA-filtered air. 10. If exhaust is directed indoors, then the system must be HEPA filtered. Prior to start of work, HEPA filtration must be verified by particulate measurement at no less than 99.97% efficiency and must not alter or change airflow/pressure relationships in other areas. 11. Exhaust into shared or recirculating HVAC systems, or other shared exhaust systems (e.g., bathroom exhaust) is not acceptable. 12. Install device on exterior of work containment to continually monitor negative pressurization. To assure proper pressure is continuously maintained, it is recommended that the device(s) has (have) a visual pressure indicator. 13. Contain all trash and debris in the work area. 14. Nonporous/smooth and cleanable containers (with a hard lid) must be used to transport trash and debris from the construction areas. These containers must be damp wipe cleaned and free of visible dust/debris before leaving the contained work area. 15. Worker clothing must be clean and free of visible dust before leaving the work area anteroom. 16. Workers must wear shoe covers prior to entry into the work area. Shoe covers must be changed prior to exiting the anteroom to the occupied space (non-work area). Damaged shoe covers must be immediately changed. 17. Install an adhesive (dust collection) mat at the entrance of the contained work area based on facility policy. Adhesive mats must be changed routinely and when visibly soiled. 18. Consider collection of particulate data during work to monitor and ensure that contaminates do not enter the occupied spaces. Routine collection of particulate samples may be used to verify HEPA filtration efficiencies. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mareković, I. What’s New in Prevention of Invasive Fungal Diseases during Hospital Construction and Renovation Work: An Overview. J. Fungi 2023, 9, 151. https://doi.org/10.3390/jof9020151
Mareković I. What’s New in Prevention of Invasive Fungal Diseases during Hospital Construction and Renovation Work: An Overview. Journal of Fungi. 2023; 9(2):151. https://doi.org/10.3390/jof9020151
Chicago/Turabian StyleMareković, Ivana. 2023. "What’s New in Prevention of Invasive Fungal Diseases during Hospital Construction and Renovation Work: An Overview" Journal of Fungi 9, no. 2: 151. https://doi.org/10.3390/jof9020151
APA StyleMareković, I. (2023). What’s New in Prevention of Invasive Fungal Diseases during Hospital Construction and Renovation Work: An Overview. Journal of Fungi, 9(2), 151. https://doi.org/10.3390/jof9020151